Literature DB >> 11069983

Phosphorylation status of the parvovirus minute virus of mice particle: mapping and biological relevance of the major phosphorylation sites.

B Maroto1, J C Ramírez, J M Almendral.   

Abstract

The core of the VP-1 and VP-2 proteins forming the T=1 icosahedral capsid of the prototype strain of the parvovirus minute virus of mice (MVMp) share amino acids sequence and a common three-dimensional structure; however, the roles of these polypeptides in the virus infection cycle differ. To gain insights into this paradox, the nature, distribution, and biological significance of MVMp particle phosphorylation was investigated. The VP-1 and VP-2 proteins isolated from purified empty capsids and from virions containing DNA harbored phosphoserine and phosphothreonine amino acids, which in two-dimensional tryptic analysis resulted in complex patterns reproducibly composed by more than 15 unevenly phosphorylated peptides. Whereas secondary protease digestions and comigration of most weak peptides in the fingerprints revealed common phosphorylation sites in the VP-1 and VP-2 subunits assembled in capsids, the major tryptic phosphopeptides were remarkably characteristic of either polypeptide. The VP-2-specific peptide named B, containing the bulk of the (32)P label of the MVMp particle in the form of phosphoserine, was mapped to the structurally unordered N-terminal domain of this polypeptide. Mutations in any or all four serine residues present in peptide B showed that the VP-2 N-terminal domain is phosphorylated at multiple sites, even though none of them was essential for capsid assembly or virus formation. Chromatographic analysis of purified wild-type (wt) and mutant peptide B digested with a panel of specific proteases allowed us to identify the VP-2 residues Ser-2, Ser-6, and Ser-10 as the main phosphate acceptors for MVMp capsid during the natural viral infection. Phosphorylation at VP-2 N-terminal serines was not necessary for the externalization of this domain outside of the capsid shell in particles containing DNA. However, the plaque-forming capacity and plaque size of VP-2 N-terminal phosphorylation mutants were severely reduced, with the evolutionarily conserved Ser-2 determining most of the phenotypic effect. In addition, the phosphorylated amino acids were not required for infection initiation or for nuclear translocation of the expressed structural proteins, and thus a role at a late stage of MVMp life cycle is proposed. This study illustrates the complexity of posttranslational modification of icosahedral viral capsids and underscores phosphorylation as a versatile mechanism to modulate the biological functions of their protein subunits.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069983      PMCID: PMC113168          DOI: 10.1128/jvi.74.23.10892-10902.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Virion assembly defect of polyomavirus hr-t mutants: underphosphorylation of major capsid protein VP1 before viral DNA encapsidation.

Authors:  R L Garcea; K Ballmer-Hofer; T L Benjamin
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

2.  DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain.

Authors:  C R Astell; E M Gardiner; P Tattersall
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

3.  Characteristics and taxonomy of Parvoviridae.

Authors:  G Siegl; R C Bates; K I Berns; B J Carter; D C Kelly; E Kurstak; P Tattersall
Journal:  Intervirology       Date:  1985       Impact factor: 1.763

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice.

Authors:  M J Merchlinsky; P J Tattersall; J J Leary; S F Cotmore; E M Gardiner; D C Ward
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

6.  Comparison of nonphosphorylated and phosphorylated species of polyomavirus major capsid protein VP1 and identification of the major phosphorylation region.

Authors:  D G Anders; R A Consigli
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

7.  Host range transforming gene of polyoma virus plays a role in virus assembly.

Authors:  R L Garcea; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  An Escherichia coli recBCsbcBrecF host permits the deletion-resistant propagation of plasmid clones containing the 5'-terminal palindrome of minute virus of mice.

Authors:  R Boissy; C R Astell
Journal:  Gene       Date:  1985       Impact factor: 3.688

9.  Mapping of the amino terminus of the H-1 parvovirus major capsid protein.

Authors:  P R Paradiso; K R Williams; R L Costantino
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  The adenovirus type 5 capsid protein IIIa is phosphorylated during an early stage of infection of HeLa cells.

Authors:  J Tsuzuki; R B Luftig
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

View more
  26 in total

1.  Interaction between parvovirus NS2 protein and nuclear export factor Crm1 is important for viral egress from the nucleus of murine cells.

Authors:  Cathy L Miller; David J Pintel
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells.

Authors:  Virginie Eichwald; Laurent Daeffler; Michèle Klein; Jean Rommelaere; Nathalie Salomé
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.

Authors:  Susanne I Lang; Stephanie Boelz; Alexandra Y Stroh-Dege; Jean Rommelaere; Christiane Dinsart; Jan J Cornelis
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  SAT: a late NS protein of porcine parvovirus.

Authors:  Zoltán Zádori; József Szelei; Peter Tijssen
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Analyses of phosphorylation events in the rubella virus capsid protein: role in early replication events.

Authors:  LokMan J Law; Carolina S Ilkow; Wen-Pin Tzeng; Matthew Rawluk; David T Stuart; Teryl K Frey; Tom C Hobman
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR.

Authors:  Iván Ventoso; Miguel Angel Sanz; Susana Molina; Juan José Berlanga; Luis Carrasco; Mariano Esteban
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

7.  Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.

Authors:  Bernhard Mani; Claudia Baltzer; Noelia Valle; José M Almendral; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  An in-frame deletion in the NS protein-coding sequence of parvovirus H-1PV efficiently stimulates export and infectivity of progeny virions.

Authors:  Nadine Weiss; Alexandra Stroh-Dege; Jean Rommelaere; Christiane Dinsart; Nathalie Salomé
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

9.  Phosphorylation of the porcine reproductive and respiratory syndrome virus nucleocapsid protein.

Authors:  Sarah K Wootton; Raymond R R Rowland; Dongwan Yoo
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.

Authors:  Mari-Paz Rubio; Alberto López-Bueno; José M Almendral
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.